First Time Loading...

Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 48.8 EUR 0.83%
Updated: Jun 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

4.3B
+2%
Assets
Growth Rates:
1 Year
+8%
3 Years
+51%
5 Years
+93%
7 Years
+156%
10 Years
+217%
2.5B
-2%
Liabilities
Growth Rates:
1 Year
+6%
3 Years
+63%
5 Years
+113%
7 Years
+264%
10 Years
+306%
1.8B
+8%
Equity
Growth Rates:
1 Year
+10%
3 Years
+37%
5 Years
+70%
7 Years
+82%
10 Years
+145%

Balance Sheet Decomposition
Recordati Industria Chimica e Farmaceutica SpA

4.3B
Assets
2.5B
Liabilities
4.3B
Assets
2.5B
Liabilities
Current Assets 1.3B
Cash & Short-Term Investments 294.7m
Receivables 581.2m
Other Current Assets 448.5m
Non-Current Assets 3B
Long-Term Investments 25m
PP&E 178.8m
Intangibles 2.7B
Other Non-Current Assets 91.3m
Current Liabilities 973.2m
Accounts Payable 288.4m
Short-Term Debt 34.1m
Other Current Liabilities 650.7m
Non-Current Liabilities 1.5B
Long-Term Debt 1.3B
Other Non-Current Liabilities 161.9m

Balance Sheet
Recordati Industria Chimica e Farmaceutica SpA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
137
226
138
302
198
188
188
245
285
222
Cash
80
173
117
273
172
141
175
231
163
195
Cash Equivalents
57
53
21
29
26
47
13
14
122
27
Total Receivables
209
204
229
282
281
374
314
350
424
542
Accounts Receivables
179
177
206
244
246
297
269
308
362
445
Other Receivables
30
26
23
38
36
77
45
43
62
97
Inventory
141
143
159
179
206
227
251
229
424
405
Other Current Assets
12
20
26
10
15
20
20
26
41
34
Total Current Assets
499
593
552
774
700
809
773
850
1 174
1 202
PP&E Net
92
109
110
103
104
133
133
131
159
179
PP&E Gross
92
109
110
103
104
133
133
131
159
179
Accumulated Depreciation
249
257
264
274
284
304
320
332
362
374
Intangible Assets
266
246
280
541
672
1 162
1 116
1 139
1 758
1 938
Goodwill
463
453
557
540
578
578
562
553
780
778
Long-Term Investments
17
32
19
24
21
39
46
34
29
22
Other Long-Term Assets
38
35
43
75
87
88
82
109
99
89
Other Assets
463
453
557
540
578
578
562
553
780
778
Total Assets
1 375
N/A
1 469
+7%
1 561
+6%
2 056
+32%
2 161
+5%
2 809
+30%
2 712
-3%
2 816
+4%
3 999
+42%
4 208
+5%
Liabilities
Accounts Payable
113
107
125
142
165
175
132
178
225
264
Accrued Liabilities
0
0
43
44
42
45
40
56
83
87
Short-Term Debt
9
10
16
17
17
13
13
9
83
100
Current Portion of Long-Term Debt
28
34
40
52
131
150
270
223
292
356
Other Current Liabilities
109
122
88
122
136
203
124
161
241
196
Total Current Liabilities
259
273
311
376
491
587
578
626
924
1 003
Long-Term Debt
286
283
294
612
641
937
778
760
1 342
1 353
Deferred Income Tax
22
22
28
18
43
43
41
27
168
144
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
21
21
24
24
23
43
37
21
19
21
Total Liabilities
588
N/A
599
+2%
657
+10%
1 029
+57%
1 198
+16%
1 610
+34%
1 436
-11%
1 435
0%
2 453
+71%
2 522
+3%
Equity
Common Stock
26
26
26
26
26
26
26
26
26
26
Retained Earnings
765
865
956
1 064
1 162
1 334
1 474
1 613
1 786
1 969
Additional Paid In Capital
84
84
84
84
84
84
84
84
84
84
Treasury Stock
31
35
77
17
146
93
88
127
150
128
Other Equity
57
70
86
130
163
152
220
214
200
265
Total Equity
787
N/A
870
+10%
904
+4%
1 027
+14%
963
-6%
1 199
+24%
1 276
+6%
1 382
+8%
1 546
+12%
1 686
+9%
Total Liabilities & Equity
1 375
N/A
1 469
+7%
1 561
+6%
2 056
+32%
2 161
+5%
2 809
+30%
2 712
-3%
2 816
+4%
3 999
+42%
4 208
+5%
Shares Outstanding
Common Shares Outstanding
204
205
205
208
204
205
206
206
205
206

See Also

Summary
REC intrinsic value, competitors valuation, and company profile.
DCF Valuation
REC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
REC stock valuation using valuation multiples.
Wall Street Estimates
REC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
REC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.